BPA Call HHSF223201610016B-75F40120F19002

Award Date 6/2/20
Potential Completion Date 7/5/22
Potential Value $19M
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Labor Hours
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Food and Drug Administration (FDA) to Accenture Federal Services LLC, doing business as Accenture National Security Services, for the CDER PMO and Informatics Governance Modernization Project. The contract has a ceiling value of $13,410,716.94 and a completion date of July 5, 2026. Accenture Federal Services, a subsidiary of the global professional services firm Accenture plc, will provide services to modernize...
This federal contract was awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to Accenture Federal Services LLC, a global professional services firm, to support the Center for Drug Evaluation and Research's (CDER) IT operations and strategy. The $7,004,449.10 contract, which is not set aside, consists of three work streams focused on program management, IT strategy development, and oversight to ensure proper planning and management of CDER's IT...
This federal contract award, valued at $8,713,885.22, was granted by the Food and Drug Administration (FDA) to Accenture Federal Services LLC, doing business as Accenture National Security Services. The contract, which is not a set-aside, is for business process improvements and implementation support, and is a Blanket Purchase Agreement (BPA) call under Accenture's existing Multiple Award Schedule (MAS) contract with the General Services Administration (GSA). Accenture has enlisted Vergys...
This is a $3,629,755.00 Firm Fixed Price definitive contract awarded by the Food and Drug Administration (FDA) to Accenture Federal Services LLC, doing business as Accenture National Security Services. The contract is for the development of a cloud-based transnational regulatory platform to support multi-region regulatory collaboration. This contract was awarded under a Broad Agency Announcement solicitation that sought advanced research and development proposals to modernize FDA's regulatory...
This is a $7,944,313.88 delivery order contract awarded to Accenture Federal Services LLC, doing business as Accenture National Security Services, by the Food and Drug Administration (FDA). The contract is for CDER Enterprise Data Governance services and is a task order under the Alliant II government-wide acquisition contract (GWAC). The contract has a period of performance through February 24, 2025 and utilizes a Time and Materials pricing type. Accenture Federal Services is a global...
This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Accenture Federal Services LLC, a global professional services company. The contract focuses on evaluating the current state of the FDA's submission process and implementing a series of iteratively designed, developed, and tested capabilities. The contract is a definitive, time and materials contract with a potential value of $1,893,888.50 and a completion date of September...
This is a $7,132,896.49 Blanket Purchase Agreement (BPA) call awarded by the Food and Drug Administration (FDA) to Accenture Federal Services LLC for Business Transformation Team (BTT) support services. The contract is an open-market award, not set-aside. Accenture Federal Services is a subsidiary of the global professional services firm Accenture plc, and has experience delivering technology and consulting services to federal agencies. For this contract, Accenture has subcontracted with...
This is a Blanket Purchase Agreement (BPA) call awarded by the Food and Drug Administration (FDA) to Accenture Federal Services LLC, a global professional services company, to provide program management support for the FDA's Enterprise Transformation Office (ETO). The purpose is to support the ETO's objectives in driving business process changes across the FDA. The contract has a ceiling value of $4,351,414.94 and a performance period through June 12, 2024. The contract was awarded under the...
The Department of Health and Human Services Food and Drug Administration awarded a $6.4 million firm fixed price delivery order contract to Accenture Federal Services LLC for business process improvement support services. Accenture will draw upon its Multiple Award Schedule contract vehicle to provide services assisting the FDA's Center for Devices and Radiological Health. One subcontract for procurement support was issued to Vergys LLC. The three-year contract will see Accenture and its...
This is a $3,385,017.21 task order awarded by the Food and Drug Administration (FDA) to Deloitte Consulting LLP under the FDA Data and Analytics Blanket Purchase Agreement (BPA). The task order is for data enrichment services to support the FDA's Center for Drug Evaluation and Research (CDER) Integrity program. The work will be performed in Silver Spring, Maryland. The contract has no small business set-aside designation. Major subcontractors include Dun & Bradstreet Inc., Proficient...

This contract was awarded by the Food and Drug Administration (FDA) to Accenture Federal Services LLC, doing business as Accenture National Security Services, for architecture and process modernization support services for the FDA's Center for Drug Evaluation and Research (CDER) informatics program management office. The contract has a ceiling value of $18,507,262.24 and a completion date of July 5, 2022. It is a Blanket Purchase Agreement (BPA) call order under the FDA Safety and Innovation Act (FDASIA) Support Services contract vehicle. Accenture Federal Services has enlisted two major subcontractors, Vergys LLC and Agisol LLC, to support this effort. The contract does not have a set-aside designation. This award contributes to the FDA's broader mission of modernizing its regulatory informatics capabilities and processes to enhance oversight of pharmaceutical development and safety.

Generated 11/21/24, 9:22 AM